Author

María Espelosin

Centro de Investigación Médica AplicadaORCID 0000-0002-8993-5747Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Ana García‐OstaiD· 2 shared Mar Cuadrado‐TejedoriD· 2 shared Alberto J. RicoiD· 1 shared Aleksandra DeczkowskaiD· 1 shared Angham Ibraheem· 1 shared Anthony H.V. SchapiraiD· 1 shared Bar Nathansohn· 1 shared Chiara BurgalettoiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Ana García‐OstaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Introducing PIGMO, a novel PIGmented MOuse model of Parkinson's disease

Julia Chocarro, Sergio Maraña, María Espelosin, Alberto J. Rico, Goiaz Ariznabarreta, Elena Lorenzo-Ramos, Mario M. Ilarduya, Rubén Hernández-Alcoceba, Miquel Chillón, Miquel Vila, Jeffrey H. Kordower, Anthony H.V. Schapira, Ana García‐Osta, Mar Cuadrado‐Tejedor, José Luis Lanciego

The paper introduces a novel mouse model of Parkinson's disease using a modified viral vector to induce pigmentation and pathological features associated with the disease.

npj Parkinson s Disease · Feb 11, 2026Peer-reviewedNeuroscience

Alzheimer's disease causes bone marrow myelopoiesis dysfunction

Miguel Angel Abellanas, Leyre Basurco, Maitreyee Purnapatre, Chiara Burgaletto, Giulia Castellani, Sarah Phoebeluc Colaiuta, Javier María Peralta Ramos, Angham Ibraheem, Sama Murad, Paola Antonello, Mariangeles Kovacs, Yuliya Androsova, Bar Nathansohn, Hannah Partney, Liora Cahalon, , Michal Schwartz

This study identifies impaired bone marrow myelopoiesis in Alzheimer's disease, driven by type I interferon signaling, and shows that targeting this pathway improves myeloid function and cognitive outcomes.

bioRxiv · Oct 6, 2025 · PreprintNeuroscience